Doctor Tattaway LLC Bethlehem, PA - 18017

Doctor Tattaway LLC is categorized under Nonclassified Establishments in Bethlehem, PA and active since 2012.

Doctor Tattaway LLC was established in 2012, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Nonclassified Establishments business, which does work in the BOTH market, and is classified as a Nonclassified Establishments, under code number 8121991 by the NAICS.

If you are seeking more information, feel free to contact Bs Di Marco Young, Owner at the company’s single location by writing to 3303 Bath Pike Unit 1, Bethlehem, Pennsylvania PA 18017 or by phoning (610) 882-8837. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Doctor Tattaway LLC
Contact Person: Bs Di Marco Young, Owner
Address: 3303 Bath Pike Unit 1, Bethlehem, Pennsylvania 18017
Phone Number: (610) 882-8837
Website Address: drtattaway.net
Annual Revenue (USD): $500.000 to $999.999
Founded: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category: Nonclassified Establishments
SIC Code: 9999
NAICS Code: 8121991
Share This Business:

Doctor Tattaway LLC was started in 2012 to provide professional Nonclassified Establishments under the SIC code 9999 and NAICS code 8121991. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Bs Di Marco Young, Owner for inquiries that concern Doctor Tattaway LLC by calling the company number (610) 882-8837, as your correspondence is most welcome. Additionally, the physical location of the single location of Doctor Tattaway LLC can be found at the coordinates 40.66128,-75.38188 as well as the street address 3303 Bath Pike Unit 1 in Bethlehem, Pennsylvania 18017.

For its online presence, you may visit Doctor Tattaway LLC’s website at drtattaway.net and engage with its social media outlets through on Twitter and on Facebook.